CA2752668A1 - Method for detecting metastasis of gi cancer - Google Patents
Method for detecting metastasis of gi cancer Download PDFInfo
- Publication number
- CA2752668A1 CA2752668A1 CA2752668A CA2752668A CA2752668A1 CA 2752668 A1 CA2752668 A1 CA 2752668A1 CA 2752668 A CA2752668 A CA 2752668A CA 2752668 A CA2752668 A CA 2752668A CA 2752668 A1 CA2752668 A1 CA 2752668A1
- Authority
- CA
- Canada
- Prior art keywords
- gcc
- gusb
- cancer
- sample
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15517209P | 2009-02-25 | 2009-02-25 | |
| US61/155,172 | 2009-02-25 | ||
| US24619709P | 2009-09-28 | 2009-09-28 | |
| US61/246,197 | 2009-09-28 | ||
| PCT/CA2010/000277 WO2010096929A1 (en) | 2009-02-25 | 2010-02-24 | Method for detecting metastasis of gi cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2752668A1 true CA2752668A1 (en) | 2010-09-02 |
Family
ID=42664977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2752668A Abandoned CA2752668A1 (en) | 2009-02-25 | 2010-02-24 | Method for detecting metastasis of gi cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110306055A1 (https=) |
| EP (2) | EP2677036A3 (https=) |
| JP (1) | JP2012518389A (https=) |
| CN (1) | CN102333887B (https=) |
| AU (1) | AU2010217160C1 (https=) |
| CA (1) | CA2752668A1 (https=) |
| WO (1) | WO2010096929A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY173390A (en) | 2009-10-23 | 2020-01-22 | Takeda Pharmaceuticals Co | Anti-gcc antibody molecules and related compositions and methods |
| US9416410B2 (en) * | 2012-02-14 | 2016-08-16 | Genetics Development Corporation | Cutoff point delta Ct. method for HER2 PCR testing in breast cancer |
| ME03560B (me) | 2012-04-27 | 2020-07-20 | Millennium Pharm Inc | MOLEKULI ANTI-GCC ANTITELA l NJIHOVA UPOTREBA U ISPITIVANJU OSETLJIVOSTI NA GCC-CILJANU TERAPIJU |
| WO2016028141A1 (en) * | 2014-08-18 | 2016-02-25 | Universiti Kebangsaan Malaysia | Method for determining prognosis of colorectal cancer |
| EP4706525A3 (en) | 2014-09-25 | 2026-04-22 | BT Bidco, Inc. | Electromechanical pill device with localization capabilities |
| EP3500177A1 (en) * | 2016-08-18 | 2019-06-26 | Mitchell Lawrence Jones | Systems for obtaining samples using ingestible devices |
| KR20230042759A (ko) | 2016-09-09 | 2023-03-29 | 비오라 쎄라퓨틱스, 인크. | 분배가능한 물질의 전달을 위한 전자기계식 섭취가능한 디바이스 |
| US10610104B2 (en) | 2016-12-07 | 2020-04-07 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| US11761032B2 (en) * | 2017-03-11 | 2023-09-19 | Yan Wang | Methods and devices for performing real time digital PCR |
| EP3900613B1 (en) | 2017-03-31 | 2023-12-27 | Biora Therapeutics, Inc. | Localization methods for an ingestible device |
| US20220249814A1 (en) | 2018-11-19 | 2022-08-11 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
| CN110819715A (zh) * | 2019-11-26 | 2020-02-21 | 华夏帮服科技有限公司 | 用于结直肠癌检测的免疫基因标志物及试剂盒 |
| CN118460719A (zh) * | 2020-03-02 | 2024-08-09 | 腾辰生物科技(上海)有限公司 | 一种分子标志物及试剂盒在辅助诊断食管癌中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5601990A (en) | 1994-09-13 | 1997-02-11 | Thomas Jefferson University | Methods of diagnosing colorectal tumors and metastasis thereof |
| EP0734264B1 (en) | 1993-10-26 | 2004-02-18 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| WO1997042506A1 (en) | 1996-05-03 | 1997-11-13 | Thomas Jefferson University | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| US7135333B1 (en) | 1997-08-07 | 2006-11-14 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| US6120995A (en) | 1997-08-07 | 2000-09-19 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| AU2001249548A1 (en) | 2000-03-27 | 2001-10-08 | Thomas Jefferson University | Compositions and methods for identifying and targeting cancer cells |
| US7138226B2 (en) | 2002-05-10 | 2006-11-21 | The University Of Miami | Preservation of RNA and morphology in cells and tissues |
| US20040018494A1 (en) * | 2002-07-25 | 2004-01-29 | Shurtliff Roxanne N | Isothermal transcription based amplification assay for detection and quantification of guanylyl cyclase C |
| DE102004024617A1 (de) * | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| WO2008045133A2 (en) * | 2006-03-03 | 2008-04-17 | Veridex, Llc | Molecular assay to predict recurrence of dukes' b colon cancer |
-
2010
- 2010-02-24 JP JP2011550395A patent/JP2012518389A/ja active Pending
- 2010-02-24 EP EP13185224.6A patent/EP2677036A3/en not_active Withdrawn
- 2010-02-24 EP EP10745780.6A patent/EP2401394B1/en not_active Not-in-force
- 2010-02-24 WO PCT/CA2010/000277 patent/WO2010096929A1/en not_active Ceased
- 2010-02-24 CA CA2752668A patent/CA2752668A1/en not_active Abandoned
- 2010-02-24 US US12/935,201 patent/US20110306055A1/en not_active Abandoned
- 2010-02-24 CN CN201080009215.XA patent/CN102333887B/zh not_active Expired - Fee Related
- 2010-02-24 AU AU2010217160A patent/AU2010217160C1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2401394B1 (en) | 2013-11-27 |
| JP2012518389A (ja) | 2012-08-16 |
| CN102333887A (zh) | 2012-01-25 |
| EP2677036A2 (en) | 2013-12-25 |
| EP2677036A3 (en) | 2014-01-22 |
| AU2010217160C1 (en) | 2015-07-02 |
| HK1165836A1 (en) | 2012-10-12 |
| WO2010096929A1 (en) | 2010-09-02 |
| EP2401394A1 (en) | 2012-01-04 |
| US20110306055A1 (en) | 2011-12-15 |
| AU2010217160B2 (en) | 2014-11-20 |
| EP2401394A4 (en) | 2012-07-11 |
| CN102333887B (zh) | 2014-04-02 |
| AU2010217160A1 (en) | 2011-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010217160C1 (en) | Method for detecting metastasis of GI cancer | |
| US10494677B2 (en) | Predicting cancer outcome | |
| Belge et al. | Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias | |
| ES2925983T3 (es) | Método para usar la expresión génica para determinar el pronóstico del cáncer de próstata | |
| Rahbari et al. | Identification of differentially expressed microRNA in parathyroid tumors | |
| Kanda et al. | The expression of melanoma-associated antigen D2 both in surgically resected and serum samples serves as clinically relevant biomarker of gastric cancer progression | |
| Fujii et al. | Evaluation of DNA and RNA quality from archival formalin‐fixed paraffin‐embedded tissue for next‐generation sequencing–Retrospective study in Japanese single institution | |
| US20070231822A1 (en) | Methods for the detection and treatment of cancer | |
| EP3541958A1 (en) | Compositions and methods for prognosing and treating colorectal cancer | |
| US20130303400A1 (en) | Multimarker panel | |
| KR102036222B1 (ko) | 당뇨병성 신증에 의한 만성신장질환 환자의 예후 예측용 마커 | |
| WO2011117586A1 (en) | Prognosis of oesophageal and gastro-oesophageal junctional cancer | |
| Kusuda et al. | Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction | |
| AU2009216723B2 (en) | BRCA1 mRNA expression predicts survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy | |
| HK1165836B (en) | Method for detecting metastasis of gi cancer | |
| US7358060B2 (en) | Method for monitoring and prognosis of disease course of gastrointestinal tumors | |
| EP4317458A1 (en) | Follicular thyroid cancer-specific marker | |
| Heaphy et al. | Prognostic biomarkers in pancreatic neuroendocrine tumors | |
| KR102036219B1 (ko) | 유전자 프로모터의 CpG 메틸화 변화를 이용한 만성신장질환의 악화 예측용 조성물 및 이의 이용 | |
| KR102036220B1 (ko) | 만성신장질환 특이적 후성학적 메틸화 마커 검출용 조성물 및 검출방법 | |
| KR102036221B1 (ko) | 만성신장질환의 예후 예측을 위한 후성 유전학적 진단 키트 개발 | |
| US20160369349A1 (en) | Novel lung cancer biomarker (liph) | |
| Troyer et al. | Quantitation of TMPRSS2: ERG fusion transcripts in frozen and paraffin embedded prostate cancers (PC) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20150219 |
|
| FZDE | Discontinued |
Effective date: 20170224 |